Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. PPH Study Group. Primary pulmonary hypertension.
Pericardial effusion was noted in 43 of 79 patients (54%) with severe primary pulmonary hypertension. Larger effusion was associated with hemodynamic and echocardiographic evidence of right heart failure, impaired exercise tolerance, and a poor 1-year prognosis.
Hinderliter
A L
AL
Department of Medicine, University of North Carolina, Chapel Hill 27599-7075, USA.
Willis
P W
PW
Long
W
W
Clarke
W R
WR
Ralph
D
D
Caldwell
E J
EJ
Williams
W
W
Ettinger
N A
NA
Hill
N S
NS
Summer
W R
WR
de Biosblanc
B
B
Koch
G
G
Li
S
S
Clayton
L M
LM
Jöbsis
M M
MM
Crow
J W
JW
D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015150:Echocardiography, Doppler; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007262:Infusions, Intravenous; D008297:Male; D010490:Pericardial Effusion / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence; D011379:Prognosis; D011669:Pulmonary Wedge Pressure; D015996:Survival Rate
D000959:Antihypertensive Agents; D011464:Epoprostenol